U.S., Dec. 10 -- An application to own the trademark for 'METFORMINT' has been filed on Jun. 20, 2025.
Owner(s):
Aspargo Laboratories, Inc.; 17 State Street, Suite 3220, NEW YORK
Goods and/or Services:
For: Pharmaceutical preparations for the treatment of diabetes and pre-diabetes, and for managing blood sugar levels; Pharmaceutical preparations for the treatment of diabetes and pre-diabetes, and for managing blood sugar levels administered as an oral spray; Anti-diabetic pharmaceuticals
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2025-12-09&serialNumber=99245377
Disclaimer: Curated by HT Syndication....